NCT02158637View on ClinicalTrials.gov

Validation Study of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

CompletedOBSERVATIONAL
Enrollment

1,100

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

March 31, 2012

Study Completion Date

March 13, 2017

Conditions
Cancer
Trial Locations (9)

10065

Memorial Sloan-Kettering Cancer, New York

19899

Christiana Care Health Services, Wilmington

29303

Gibbs Cancer Center, Spartanburg

55905

Mayo Clinic, Rochester

70809

The Cancer Program of Our Lady of the Lake and Mary Bird Perkins, Baton Rouge

77030

MD Anderson Cancer Center, Houston

92868

St. Joseph Hospital of Orange, Orange

06102

Hartford Hospital, Hartford

02215

Dana-Farber Cancer Institute, Boston

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER

NCT02158637 - Validation Study of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) | Biotech Hunter | Biotech Hunter